MiR-199a-3p inhibits aurora kinase a and attenuates prostate cancer growth: New avenue for prostate cancer treatment

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1541-1549

  Qu, Yi ^a   Huang, Xiang ^b   Li, Zhiqing ^b   Liu, Junyan ^a   Wu, Jinlin ^a   Chen, Dapeng ^a   Zhao, Fengyan ^a   Mu, Dezhi ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; AURORA A KINASE; MICRORNA; MICRORNA 199A 3P; MICRORNA 199A 3P AGOMIR; UNCLASSIFIED DRUG; AURKA PROTEIN, HUMAN; AZACITIDINE; LUCIFERASE; MESSENGER RNA; MIRN199 MICRORNA, HUMAN; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL CYCLE ARREST; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DNA METHYLATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUMINESCENCE; METABOLISM; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; AURORA KINASE A; AZACITIDINE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; LUMINESCENCE; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA, MESSENGER;

EID: 84899515887     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.017     Document Type: Article

References (17)

1. A. Bar-Shira, J.H. Pinthus, U. Rozovsky, M. Goldstein, W.R. Sellers, Y. Yaron, Z. Eshhar, and A. Orr-Urtreger Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft Cancer Res 62 2002 6803 6807
2. E.C. Lee, A. Frolov, R. Li, G. Ayala, and N.M. Greenberg Targeting Aurora kinases for the treatment of prostate cancer Cancer Res 66 2006 4996 5002
3. Y. Qu, L. Zhang, M. Mao, F. Zhao, X. Huang, C. Yang, Y. Xiong, and D. Mu Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer Cancer Gene Ther 15 2008 517 525
4. D.P. Battel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. J.H. Chua, A. Armugam, and K. Jeyaseelan MicroRNAs: biogenesis, function and applications Curr Opin Mol Ther 11 2009 189 199
6. T.A. Farazi, J.I. Hoell, P. Morozov, and T. Tuschl MicroRNAs in human cancer Adv Exp Med Biol 774 2013 1 20
7. P. Sethupathy, and F.S. Collins MicroRNA target site polymorphisms and human disease Trends Genet 24 2008 489 497
8. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
9. H.H. Cheung, A.J. Davis, T.L. Lee, A.L. Pang, S. Nagrani, O.M. Rennert, and W.Y. Chan Methylation of an intronic region regulates miR-199a in testicular tumor malignancy Oncogene 30 2011 3404 3415
10. K.P. Porkka, M.J. Pfeiffer, K.K. Waltering, R.L. Vessella, T.L. Tammela, and T. Visakorpi MicroRNA expression profiling in prostate cancer Cancer Res 67 2007 6130 6135
11. J. Szczyrba, E. Löprich, S. Wach, V. Jung, G. Unteregger, S. Barth, R. Grobholz, W. Wieland, R. Stöhr, A. Hartmann, B. Wullich, and F. Grässer The microRNA profile of prostate carcinoma obtained by deep sequencing Mol Cancer Res 8 2010 529 538
12. K. Sakurai, C. Furukawa, T. Haraguchi, K. Inada, K. Shiogama, T. Tagawa, S. Fujita, Y. Ueno, A. Ogata, M. Ito, Y. Tsutsumi, and H. Iba MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers Cancer Res 71 2011 1680 1689
13. Z. Duan, E. Choy, D. Harmon, X. Liu, M. Susa, H. Mankin, and F. Hornicek MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration Mol Cancer Ther 10 2011 1337 1345
14. D. Wan, S. He, B. Xie, G. Xu, W. Gu, C. Shen, Y. Hu, X. Wang, Q. Zhi, and L. Wang Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers Med Oncol 30 2013 378
15. E.A. Harrington, D. Bebbington, J. Moore, R.K. Rasmussen, A.O. Ajose-Adeogun, T. Nakayama, J.A. Graham, C. Demur, T. Hercend, A. Diu-Hercend, M. Su, J.M. Golec, and K.M. Miller VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo Nat Med 10 2004 262 267
16. M.G. Manfredi, J.A. Ecsedy, K.A. Meetze, S.K. Balani, O. Burenkova, W. Chen, K.M. Galvin, K.M. Hoar, J.J. Huck, P.J. LeRoy, E.T. Ray, T.B. Sells, B. Stringer, S.G. Stroud, T.J. Vos, G.S. Weatherhead, D.R. Wysong, M. Zhang, J.B. Bolen, and C.F. Claiborne Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase Proc Natl Acad Sci U S A 104 2007 4106 4111
17. T. Hata, T. Furukawa, M. Sunamura, S. Egawa, F. Motoi, N. Ohmura, T. Marumoto, H. Saya, and A. Horii RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells Cancer Res 65 2005 2899 2905